Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Ultrasis Plc's Subsidiary Wins Contracts


Monday, 18 Nov 2013 02:00am EST 

Ultrasis Plc announced that its recently-acquired screening and wellbeing subsidiary, Screenetics UK Limited (Screenetics), has won three new contracts with customers spanning the public and private sectors. The value of the contracts is an estimated £2 million per annum. The revenues are partly conditional on performance, but, based on past experience, Screenetics is confident of fulfilling the contract criteria. Ultrasis acquired Screenetics on October 4, 2013 as part of its strategy to broaden the range of products and services it provides and to enable it to become a provider of wellbeing, health and social care services. The contracts relate to the provision of 9,500 flu vaccinations (currently being delivered, one year contract); health screenings as part of a salary sacrifice scheme to a public sector body (commences February 2014 ,three year contract); and employee screening to a UK corporate company (commences spring 2014, initially one year contract). 

Company Quote

0.6
-0.02 -3.23%
16 Sep 2014